Literature DB >> 22751441

MiR-1246: a new link of the p53 family with cancer and Down syndrome.

Jun-Ming Liao1, Xiang Zhou, Yu Zhang, Hua Lu.   

Abstract

Since the discovery of miRNAs, a number of miRNAs have been identified as p53's transcriptional targets. Most of them are involved in regulation of the known p53 functions, such as cell cycle, apoptosis and senescence. Our recent study revealed miR-1246 as a novel target of p53 and its analogs p63 and p73 to suppress the expression of DYRK1A and consequently activate NFAT, both of which are associated with Down syndrome and possibly with tumorigenesis. This finding suggests that miR-1246 might serve as a likely link of the p53 family with Down syndrome. Here, we provide some prospective views on the potential role of the p53 family in Down syndrome via miR-1246 and propose a new p53-miR-1246-DYRK1A-NFAT pathway in cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22751441      PMCID: PMC3409007          DOI: 10.4161/cc.20809

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  73 in total

1.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

Review 2.  The mechanism of action of cyclosporin A and FK506.

Authors:  S L Schreiber; G R Crabtree
Journal:  Immunol Today       Date:  1992-04

3.  Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia.

Authors:  M J Ball; K Nuttall
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

4.  CD40 ligand is expressed and functional on activated neonatal T cells.

Authors:  J B Splawski; J Nishioka; Y Nishioka; P E Lipsky
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

5.  A microRNA component of the p53 tumour suppressor network.

Authors:  Lin He; Xingyue He; Lee P Lim; Elisa de Stanchina; Zhenyu Xuan; Yu Liang; Wen Xue; Lars Zender; Jill Magnus; Dana Ridzon; Aimee L Jackson; Peter S Linsley; Caifu Chen; Scott W Lowe; Michele A Cleary; Gregory J Hannon
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 6.  The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications.

Authors:  B Hämmerle; C Elizalde; J Galceran; W Becker; F J Tejedor
Journal:  J Neural Transm Suppl       Date:  2003

7.  Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31.

Authors:  G Dolganov; S Bort; M Lovett; J Burr; L Schubert; D Short; M McGurn; C Gibson; D B Lewis
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

8.  Transcription of the murine interleukin 5 gene is regulated by multiple promoter elements.

Authors:  K S Stranick; F Payvandi; D N Zambas; S P Umland; R W Egan; M M Billah
Journal:  J Biol Chem       Date:  1995-09-01       Impact factor: 5.157

9.  The interleukin-8 AP-1 and kappa B-like sites are genetic end targets of FK506-sensitive pathway accompanied by calcium mobilization.

Authors:  S Okamoto; N Mukaida; K Yasumoto; N Rice; Y Ishikawa; H Horiguchi; S Murakami; K Matsushima
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

10.  Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation.

Authors:  J W Rooney; Y L Sun; L H Glimcher; T Hoey
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  27 in total

Review 1.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

2.  miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells.

Authors:  Wei Li; Ya-Fen Wu; Rong-Hua Xu; Hui Lu; Cui Hu; Hua Qian
Journal:  Mol Cell Biochem       Date:  2014-06-01       Impact factor: 3.396

Review 3.  New insights into p53 functions through its target microRNAs.

Authors:  Jun-Ming Liao; Bo Cao; Xiang Zhou; Hua Lu
Journal:  J Mol Cell Biol       Date:  2014-04-15       Impact factor: 6.216

4.  miR profile in pagetic osteoclasts: from large-scale sequencing to gene expression study.

Authors:  Hoang Dong Nguyen; Martine Bisson; Michelle Scott; Gilles Boire; Luigi Bouchard; Sophie Roux
Journal:  J Mol Med (Berl)       Date:  2021-10-05       Impact factor: 4.599

5.  Identification of ncRNAs as potential therapeutic targets in multiple sclerosis through differential ncRNA - mRNA network analysis.

Authors:  Haritz Irizar; Maider Muñoz-Culla; Matías Sáenz-Cuesta; Iñaki Osorio-Querejeta; Lucía Sepúlveda; Tamara Castillo-Triviño; Alvaro Prada; Adolfo Lopez de Munain; Javier Olascoaga; David Otaegui
Journal:  BMC Genomics       Date:  2015-03-28       Impact factor: 3.969

Review 6.  The microRNA feedback regulation of p63 in cancer progression.

Authors:  Changwei Lin; Xiaorong Li; Yi Zhang; Yihang Guo; Jianyu Zhou; Kai Gao; Jing Dai; Gui Hu; Lv Lv; Juan Du; Yi Zhang
Journal:  Oncotarget       Date:  2015-04-20

7.  The microRNA-1246 promotes metastasis in non-small cell lung cancer by targeting cytoplasmic polyadenylation element-binding protein 4.

Authors:  Weihua Huang; Huifen Li; Rongcheng Luo
Journal:  Diagn Pathol       Date:  2015-07-25       Impact factor: 2.644

8.  Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma.

Authors:  Junying Chen; Desheng Yao; Yue Li; Hong Chen; Chanjuan He; Nan Ding; Yan Lu; Tingyu Ou; Shan Zhao; Li Li; Fengyi Long
Journal:  Int J Mol Med       Date:  2013-06-21       Impact factor: 4.101

Review 9.  Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.

Authors:  Albert E Berman; Olga V Leontieva; Venkatesh Natarajan; James A McCubrey; Zoya N Demidenko; Mikhail A Nikiforov
Journal:  Oncotarget       Date:  2012-12

10.  Global effect of inauhzin on human p53-responsive transcriptome.

Authors:  Jun-Ming Liao; Shelya X Zeng; Xiang Zhou; Hua Lu
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.